Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.150
+0.150 (5.00%)
At close: Apr 1, 2026, 4:00 PM EDT
3.094
-0.056 (-1.77%)
After-hours: Apr 1, 2026, 7:35 PM EDT
Absci Employees
Absci had 140 employees as of December 31, 2025. The number of employees decreased by 17 or -10.83% compared to the previous year.
Employees
140
Change (1Y)
-17
Growth (1Y)
-10.83%
Revenue / Employee
$20,000
Profits / Employee
-$822,736
Market Cap
482.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 140 | -17 | -10.83% | 140 | 0 |
| Dec 31, 2024 | 157 | 1 | 0.64% | 156 | 1 |
| Dec 31, 2023 | 156 | -37 | -19.17% | 155 | 1 |
| Dec 31, 2022 | 193 | -19 | -8.96% | 193 | 0 |
| Dec 31, 2021 | 212 | 110 | 107.84% | 211 | 1 |
| Sep 30, 2021 | 207 | 105 | 102.94% | 207 | 0 |
| Jun 30, 2021 | 169 | - | - | 169 | 0 |
| Mar 31, 2021 | 102 | - | - | 102 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Entrada Therapeutics | 152 |
| Nautilus Biotechnology | 130 |
| Verastem | 102 |
| enGene Holdings | 82 |
| Assembly Biosciences | 73 |
| Atea Pharmaceuticals | 55 |
ABSI News
- 7 days ago - Absci: Downgrade To 'Hold' As ABS-101 On Back Burner And Pivot To ABS-201 - Seeking Alpha
- 8 days ago - Absci Corporation (ABSI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 9 days ago - Absci Corporation (ABSI) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript - Seeking Alpha
- 26 days ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - Absci Corporation (ABSI) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 4 weeks ago - Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - GlobeNewsWire
- 5 weeks ago - Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - GlobeNewsWire